Back to search

Switzerland· 58151004

Piperacillin/Tazobactam Sandoz 2,25 g, Pulver zur Herstellung einer Infusionslösung

A piperacillin und beta-lactamase-inhibitor product containing piperacillinum, tazobactamum, registered in Switzerland by Sandoz Pharmaceuticals AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC J01CR05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPiperacillin/Tazobactam Sandoz 2,25 g…ATCJ01CR05REGISTER NO.58151004PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Piperacillin und beta-lactamase-inhibitor is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CR05 (piperacillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Piperacillin und beta-lactamase-inhibitor · ATC J01CR05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of piperacillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (14 g), so markets compare like for like.

  • Switzerland: $158.68 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Piperacillin und beta-lactamase-inhibitor · price per daily dose (14 g)

USD · FX 28 Sept 2026

  • CH Switzerland$158.68
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
piperacillinum, tazobactamum
Manufacturer
Sandoz Pharmaceuticals AG
Country
Switzerland (CH)
ATC code
J01CR05
ATC class
Piperacillin und Beta-Lactamase-Inhibitor
Defined daily dose
14 g, P
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680581510049
    Durchstf 10 Stk
    CHF 122.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for piperacillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Piperacillin und beta-lactamase-inhibitor · interactions on record

111 records

  • 5 severe
  • 22 moderate
  • 4 minor
  • 80 info

Most severe, free to view

  • VancomycinA07AA09severe
  • VancomycinJ01XA01severe
  • MethotrexateL01BA01severe
  • MethotrexateL04AX03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Piperacillin und beta-lactamase-inhibitor in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piperacillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Ibigen
  • Belgium · Piperacillin/Tazobactam Eg (Eurogenerics), Piperacillin/Tazobactam Eugia
  • Bulgaria · Piperacillin/Tazobactam Kabi, Перазин
  • Cyprus · Pazoctam, Piperacillin + Tazobactam Viatris
  • Czechia · Apiz, Kezutin
  • Germany · Piperacillin Plus Tazobactam Eberth, Piperacillin/Tazobactam Accord
  • Denmark · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Estonia · Eriz, Piperacillin/Tazobactam Eugia
  • Spain · Piperacilina/Tazobactam Accord Healthcare, Piperacilina/Tazobactam Aurovitas
  • Finland · Piperacillin / Tazobactam Qilu, Piperacillin/Tazobactam Antibiotice
  • France · Piperacilline Tazobactam Viatris, Piperacilline/Tazobactam Arrow
  • United Kingdom (Northern Ireland) · Piperacillin / Tazobactam Qilu, Piperacillin Tazobactam Mylan
  • Greece · Gramenox, Piperacillin + Tazobactam Viatris
  • Croatia · Acipirin, Piperacilin/Tazobaktam Accord
  • Hungary · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Kabi
  • Ireland · Piperacillin Tazobactam, Piperacillin/Tazobactam
  • Iceland · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam Sandoz
  • Italy · Ibitazina, Limerik
  • Lithuania · Eratia, Piperacillin/Tazobactam Kalceks
  • Luxembourg · Piperacillin/Tazobactam Eurogenerics, Piperacillin/Tazobactam Kabi
  • Latvia · Eratia, Piperacillin/Tazobactam Eugia
  • Malta · Piperacillin Tazobactam Viatris, Piperacillin/Tazobactam Aptapharma
  • Netherlands · Piperacillin/Tazobactam Tillomed, Piperacilline/Tazobactam Accord
  • Norway · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Poland · Piperacillin + Tazobactam Accord, Piperacillin + Tazobactam Aptapharma
  • Portugal · Piperacilina + Tazobactam Accord, Piperacilina + Tazobactam Aurobindo
  • Romania · Perasin, Piperacilină/Tazobactam Aptapharma
  • Sweden · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
  • Slovenia · Piperacilin/Tazobaktam Accord, Piperacilin/Tazobaktam Aptapharma
  • Slovakia · Piperacilin Comp. Sandoz, Piperacillin/Tazobactam Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd4f3cab-6248-4744-93ca-6463568f3b40
GET /v1/drugs/fd4f3cab-6248-4744-93ca-6463568f3b40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "piperacillinum 2 g + tazobactamum 0.25 g",
  "valid_from": "2025-07-01",
  "limitations": null,
  "galenic_form": "Trockensub 2.25 g",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-07-01",
  "self_retention_pct": 10
}

See everything about piperacillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.